Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08003, Spain.
Department of Experimental Oncology, European Institute of Oncology (IEO), Milan 20139, Italy.
Genes Dev. 2022 Apr 1;36(7-8):451-467. doi: 10.1101/gad.349115.121. Epub 2022 Apr 21.
Genome organization plays a pivotal role in transcription, but how transcription factors (TFs) rewire the structure of the genome to initiate and maintain the programs that lead to oncogenic transformation remains poorly understood. Acute promyelocytic leukemia (APL) is a fatal subtype of leukemia driven by a chromosomal translocation between the promyelocytic leukemia (PML) and retinoic acid receptor α (RARα) genes. We used primary hematopoietic stem and progenitor cells (HSPCs) and leukemic blasts that express the fusion protein PML-RARα as a paradigm to temporally dissect the dynamic changes in the epigenome, transcriptome, and genome architecture induced during oncogenic transformation. We found that PML-RARα initiates a continuum of topologic alterations, including switches from A to B compartments, transcriptional repression, loss of active histone marks, and gain of repressive histone marks. Our multiomics-integrated analysis identifies as an early down-regulated gene in PML-RARα-driven leukemogenesis. Furthermore, we characterized the dynamic alterations in the -regulatory network during APL progression and demonstrated that ectopic overexpression can suppress self-renewal and reverse the differentiation block induced by PML-RARα. Our study provides a comprehensive in vivo temporal dissection of the epigenomic and topological reprogramming induced by an oncogenic TF and illustrates how topological architecture can be used to identify new drivers of malignant transformation.
基因组组织在转录中起着关键作用,但转录因子 (TFs) 如何重塑基因组结构以启动和维持导致致癌转化的程序仍知之甚少。急性早幼粒细胞白血病 (APL) 是一种致命的白血病亚型,由早幼粒细胞白血病 (PML) 和维甲酸受体 α (RARα) 基因之间的染色体易位驱动。我们使用表达融合蛋白 PML-RARα 的原代造血干/祖细胞 (HSPC) 和白血病母细胞作为范例,从时间上解析致癌转化过程中诱导的表观基因组、转录组和基因组结构的动态变化。我们发现 PML-RARα 引发了一系列拓扑变化,包括从 A 到 B 隔室的转变、转录抑制、活性组蛋白标记的丧失和抑制性组蛋白标记的获得。我们的多组学综合分析将 确定为 PML-RARα 驱动的白血病发生中的早期下调基因。此外,我们描述了 APL 进展过程中 - 调节网络的动态变化,并表明异位 过表达可以抑制自我更新并逆转 PML-RARα 诱导的分化阻滞。我们的研究提供了对致癌 TF 诱导的表观基因组和拓扑重编程的全面体内时间剖析,并说明了拓扑结构如何用于鉴定恶性转化的新驱动因素。